All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Although several studies have shown antacid medications'including over-the-counter treatments like Tums and Pepcid as well as prescription H2 blockers and proton-pump inhibitors'interact badly with protease inhibitors, a new study suggests Reyataz might not be affected. Researchers in Paris compared blood-based concentrations of Reyataz in two groups: 13 HIV patients who took both the protease inhibitor and a proton-pump inhibitor, and 79 HIVers taking only Reyataz. There was no difference between the two groups. 'In clinical practice, proton-pump inhibitors appear to be compatible with boosted Reyataz therapy,' the researchers wrote in the November 4 edition of the journal AIDS, but they cautioned that a large-scale study is needed to confirm their findings.
From our Sponsors
Most Popular
The road to U=U: How science has been liberating HIV+ people for a decade
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
How to find an HIV-competent healthcare provider, according to advocates
Latest Stories
A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
Why affirming faith communities belong in the fight to end HIV
Navigating a new HIV diagnosis? Advocates say community is key
Gay Wine Weekend toasts 15 years of raising funds for HIV
A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice
Zero HIV Stigma Day: The epidemic we still choose to ignore
National HIV Prevention Day: Awareness is my superpower
Federal court clarifies that people with HIV can join the military again
Can a single infusion of immune cells suppress HIV for years?
National HIV advocacy group's CEO rejects claims of crisis
Beyond awareness: How youth leadership is reshaping the HIV response
Saving public health? AIDS United's new CEO has a plan
Struggling with daily HIV meds? Monthly shots may be the answer
Trending stories
Recommended Stories for You

































































